|
|
Exchange: |
Nasdaq National Market |
Security
Type: |
Common |
Shares
Out: |
152,273,000 |
Market
Cap: |
N/A |
Last
Volume: |
8,789,578 |
Avg
Vol: |
4,096,352 |
52
Week Range: |
$16.96 - $16.96 |
|
Level
I Sector: |
Health Care |
Level
II Sector: |
Drugs |
Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
Rankings:
|
Insider 3 Months : - |
Insider 6 Months : - |
Insider 3/6 Months : - |
|
Guru Rank Number : - |
Guru Rank Value : - |
Guru Occurances : - |
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
3m +/-:
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
Actions:
|
|
|
B |
Buy |
S |
Sell |
OE |
Option
Exercised |
A |
Acquired |
D |
Disposed |
AB |
Automatic
Buy |
AS |
Automatic
Sell |
IO |
Initial
Ownership |
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
|
|
Summary (Direct Transactions Only) |
3 Months |
6 Months |
12 Months |
24 Months |
Total Shares Bought |
0 |
0 |
0 |
0 |
Total Buy Value |
$0 |
$0 |
$0 |
$0 |
Total People Bought |
0 |
0 |
0 |
0 |
Total Buy Transactions |
0 |
0 |
0 |
0 |
Total Shares Sold |
0 |
0 |
0 |
0 |
Total Sell Value |
$0 |
$0 |
$0 |
$0 |
Total People Sold |
0 |
0 |
0 |
0 |
Total Sell Transactions |
0 |
0 |
0 |
0 |
End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
Kaye Randall |
Sr. VP, Chief Medical Officer |
|
2010-06-13 |
4 |
D |
$2.71 |
$3,921 |
D/D |
(1,447) |
303,483 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-06-13 |
4 |
D |
$2.71 |
$3,577 |
D/D |
(1,320) |
270,047 |
|
- |
|
Kaye Randall |
Sr. VP, Chief Medical Officer |
|
2010-06-07 |
4 |
AS |
$2.38 |
$119,115 |
D/D |
(50,000) |
304,930 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-05-03 |
4 |
AS |
$3.06 |
$201,376 |
D/D |
(65,906) |
271,367 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-04-30 |
4 |
AS |
$3.31 |
$132,372 |
D/D |
(40,000) |
337,273 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-04-08 |
4 |
AS |
$3.01 |
$30,100 |
D/D |
(10,000) |
377,273 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-03-29 |
4 |
AS |
$2.60 |
$78,000 |
D/D |
(30,000) |
387,273 |
|
- |
|
Ocampo Christine |
Vice President, Finance |
|
2010-03-16 |
4 |
AS |
$2.08 |
$32,283 |
D/D |
(15,518) |
41,982 |
|
- |
|
Kaye Randall |
Sr. VP, Chief Medical Officer |
|
2010-03-13 |
4 |
D |
$2.13 |
$3,084 |
D/D |
(1,448) |
354,930 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-03-13 |
4 |
D |
$2.13 |
$2,805 |
D/D |
(1,317) |
417,273 |
|
- |
|
Mathews Charles |
Director |
|
2010-02-18 |
4/A |
A |
$0.00 |
$0 |
D/D |
40,000 |
210,094 |
|
- |
|
Mathews Charles |
Director |
|
2010-02-18 |
4 |
A |
$0.00 |
$0 |
I/I |
40,000 |
211,969 |
|
- |
|
Austin Stephen G |
Director |
|
2010-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
210,094 |
|
- |
|
Mazzo David J |
Director |
|
2010-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
208,594 |
|
- |
|
Whitcup Scott M |
Director |
|
2010-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
207,594 |
|
- |
|
Wheeler Craig A |
Director |
|
2010-02-18 |
4 |
A |
$0.00 |
$0 |
D/D |
40,000 |
267,594 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-01-05 |
4/A |
S |
$1.93 |
$29,276 |
D/D |
(15,025) |
418,590 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-01-05 |
4 |
S |
$1.93 |
$29,276 |
D/D |
(15,025) |
418,001 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-01-04 |
4/A |
S |
$1.88 |
$38,005 |
D/D |
(20,000) |
433,615 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-01-04 |
4/A |
D |
$1.97 |
$101,567 |
D/D |
(51,557) |
453,615 |
|
- |
|
Kaye Randall |
Sr. VP, Chief Medical Officer |
|
2010-01-04 |
4/A |
D |
$1.97 |
$55,316 |
I/I |
(28,079) |
368,878 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-01-04 |
4 |
S |
$1.88 |
$38,005 |
D/D |
(20,000) |
433,026 |
|
- |
|
Katkin Keith |
President and CEO |
|
2010-01-04 |
4 |
D |
$1.97 |
$102,728 |
D/D |
(52,146) |
453,026 |
|
- |
|
Kaye Randall |
Sr. VP, Chief Medical Officer |
|
2010-01-04 |
4 |
D |
$1.97 |
$56,143 |
I/I |
(28,499) |
368,458 |
|
- |
|
Katkin Keith |
President and CEO |
|
2009-12-15 |
4 |
S |
$1.81 |
$68,025 |
D/D |
(37,335) |
505,172 |
|
- |
|
276 Records found
|
|
Page 6 of 12 |
|
|